FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

STILL TIMOTHY I 		2. Issuer Name and Ticker or Trading Symbol

HEMOSENSE INC [ HEM ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Exec. VP, Sales and Marketing
(Last)          (First)          (Middle)

C/O HEMOSENSE, INC., 651 RIVER OAKS PKWY 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/18/2007
(Street)

SAN JOSE, CA 95134
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/18/2007     M    65000   A $0.80   65000   D    
Common Stock   10/18/2007     M    10832   A $0.80   10832   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   $0.80   10/18/2007     M        65000      (1) 7/22/2014   Common Stock   65000   $0   0   D    
Stock Option (right to buy)   $0.80   10/18/2007     M        10832      (2) 2/17/2015   Common Stock   10832   $0   1668   D    

Explanation of Responses:
( 1)  25% of the shares subject to the option vested on June 7, 2004 and from such time, 1/48 of the total number of shares subject to the option vested on the first calendar day of each month thereafter. The option includes provisions for 100% change-in-control acceleration and 20% acceleration upon the effective date of the Company's initial public offering.
( 2)  25% of the shares subject to the option vested on February 17, 2005 and from such time, 1/48 of the total number of shares subject to the option vested on the first calendar day of each month thereafter. The option includes provisions for 100% change-in-control acceleration and 20% acceleration upon the effective date of the Company's initial public offering.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
STILL TIMOTHY I
C/O HEMOSENSE, INC.
651 RIVER OAKS PKWY
SAN JOSE, CA 95134

Exec. VP, Sales and Marketing

Signatures
/s/ TIMOTHY I. STILL 10/19/2007
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Hemosense (AMEX:HEM)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Hemosense 차트를 더 보려면 여기를 클릭.
Hemosense (AMEX:HEM)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Hemosense 차트를 더 보려면 여기를 클릭.